يعرض 1 - 10 نتائج من 13 نتيجة بحث عن '"Progesterone"', وقت الاستعلام: 1.87s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    المصدر: BMC Cancer
    BMC Cancer; 10 (2010)
    BMC Cancer, Vol 10, Iss 1, p 639 (2010)

    وصف الملف: application/pdf

  8. 8

    المساهمون: University of Zurich, Krenacs, Tibor

    المصدر: BMC Cancer, Vol 13, Iss 1, p 50 (2013)
    BMC Cancer

    وصف الملف: 1471-2407-13-50.pdf - application/pdf

  9. 9
  10. 10

    المساهمون: [Adamo B, Vidal M] Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain. [Bellet M, Gómez-Pardo P] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. [Paré L] Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. [Pascual T] Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. [Pérez Fidalgo JA] Hospital Clínico Universitario de Valencia, Valencia, Spain. INCLIVA Instituto de Investigación Sanitaria, Universitat de València, Valencia, Spain. Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Madrid, Spain, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Recercat. Dipósit de la Recerca de Catalunya
    instname
    Breast Cancer Research : BCR
    Recercat: Dipósit de la Recerca de Catalunya
    Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
    Dipòsit Digital de la UB
    Universidad de Barcelona
    Breast Cancer Research, Vol 21, Iss 1, Pp 1-12 (2019)

    مصطلحات موضوعية: Oncology, compuestos heterocíclicos::alcaloides::alcaloides de indol::alcaloides de secologanina y triptamina::alcaloides de la vinca::vinorelbina [COMPUESTOS QUÍMICOS Y DROGAS], Receptors, Steroid, Receptor, ErbB-2, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Gene Expression, factores biológicos::biomarcadores::marcadores tumorales [COMPUESTOS QUÍMICOS Y DROGAS], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Medicaments antineoplàstics, Breast cancer, 0302 clinical medicine, Surgical oncology, Antineoplastic Combined Chemotherapy Protocols, Càncer, Cancer, Otros calificadores::Otros calificadores::/tratamiento farmacológico [Otros calificadores], Aged, 80 and over, 0303 health sciences, Letrozole, Vinorelbine, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Postmenopause, Hormone receptor, 030220 oncology & carcinogenesis, Female, Lung cancer, Research Article, medicine.drug, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Heterocyclic Compounds::Alkaloids::Indole Alkaloids::Secologanin Tryptamine Alkaloids::Vinca Alkaloids::Vinorelbine [CHEMICALS AND DRUGS], Breast Neoplasms, lcsh:RC254-282, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, Window of opportunity, Statistical significance, Internal medicine, Progesterone receptor, Biomarkers, Tumor, medicine, Humans, Metronomic, Biological Factors::Biomarkers::Biomarkers, Tumor [CHEMICALS AND DRUGS], Adverse effect, Aged, 030304 developmental biology, business.industry, Marcadors tumorals, Neoplasias::Neoplasias por Localización::Neoplasias de la Mama [ENFERMEDADES], medicine.disease, Antineoplastic Agents, Phytogenic, Compuestos Heterocíclicos::Alcaloides::Alcaloides Indólicos::Alcaloides de Triptamina Secologanina::Alcaloides de la Vinca::Vinorelbina [COMPUESTOS QUÍMICOS Y DROGAS], Administration, Metronomic, Mama - Càncer - Tractament, Càncer de pulmó, business

    وصف الملف: application/pdf